Evidence map›Paper›PMID 42830900›Full record

ArticleESMO real world data and digital oncology2026

From electronic health records to real-world evidence: Savana Next-Generation Registry digital solution.

J Marin-Corral, N Iglesias, S Menke, D Casadevall, I H Medrano, J Tello, A J Muñoz, B E Miller, H Mehanna, M Rodríguez and 1 more

Abstract read
In one paragraph

Article in ESMO real world data and digital oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

J Marin-CorralScientific Department, Medsavana S.L., Madrid, Spain.
N IglesiasTechnological Department, Medsavana S.L., Madrid, Spain.
S MenkeTechnological Department, Medsavana S.L., Madrid, Spain.
D CasadevallScientific Department, Medsavana S.L., Madrid, Spain.
I H MedranoExecutive Leadership, Medsavana S.L., Madrid, Spain.
J TelloExecutive Leadership, Medsavana S.L., Madrid, Spain.
A J MuñozDepartment of Medical Oncology, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain.
B E MillerCOPD Foundation, Miami, USA.
H MehannaDepartment of Cancer and Genomic Sciences, Institute of Head and Neck Studies and Education, University of Birmingham, Birmingham, UK.
M RodríguezExecutive Leadership, Medsavana S.L., Madrid, Spain.
M TabernaScientific Department, Medsavana S.L., Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The secondary use of electronic health records (EHRs) offers a major opportunity to generate real-world evidence (RWE) to complement clinical trials and support regulatory and clinical decision making. However, a large proportion of clinically relevant information remains embedded in unstructured text, limiting its systematic reuse, particularly in complex areas such as oncology. This article presents the Savana Next-Generation Registry (SNGR), a methodology for building oncology-focused registries through the extraction and structuring of unstructured EHR data. Materials and methods: SNGR uses EHRead®, a clinical natural language processing engine trained on multilingual EHRs, to transform free-text data into standardized clinical variables. By extracting clinically relevant information from unstructured clinical narratives, the approach enriches existing structured EHR data, enabling more complete and clinically meaningful datasets. The solution integrates medical expert input, terminology curation, and a multilayer quality assurance framework designed to support data validity, reproducibility, and traceability. Results: SNGR is aligned with European regulatory frameworks, including the European Health Data Space, General Data Protection Regulation, and Data Act, enabling compliant and interoperable secondary data use. To date, it has supported over 65 real-world use cases across multiple therapeutic areas, including oncology, generating >30 peer-reviewed publications and analysis-ready datasets in multicenter and international collaborations. Conclusions: SNGR demonstrates how unstructured EHR data can be transformed into analysis-ready datasets for RWE generation. It provides a scalable and methodologically robust infrastructure for next-generation registries, particularly suited for oncology and other data-rich clinical domains, supporting research, drug development, and health care decision making. As the framework evolves, future studies will continue to expand its evidence base.

Indexed as

health economics outcomes research (HEOR)natural language processing (NLP)next-generation registry (NGR)real-world data (RWD)real-world evidence (RWE)regulatory-ready framework

Identifiers

PMID42830900
PMCPMC13634081

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.